Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ.-Y. Douillard, R. Sidhu, Salvatore Siena et al.|Annals of Oncology|2014Cited by 603
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trialJ Cassidy, L. Garrison, Patrick G. Johnston et al.|British Journal of Cancer|2006Cited by 125
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancerGeoff Chong, J Carmichael, Anish Bhatnagar et al.|Annals of Oncology|2005Cited by 32